Showing results (21-30 of 91) with videos related to
Sort By:
Pageof 10
Plos One|February 24, 2018
Correction: Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infectionNadia Echebli, Nicolas Tchitchek, Stéphanie Dupuy, et al.Plos Pathogens|February 6, 2014
Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaquesTimothée Bruel, Stéphanie Dupuy, Thomas Démoulins, et al.Frontiers in Immunology|March 14, 2022
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 VaccineFloriane Gallais, Pierre Gantner, Delphine Planas, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activityRomila Moirangthem, Sapir Cordela, Dina Khateeb, et al.Open Forum Infectious Diseases|August 11, 2021
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated IndividualSolen Kernéis, Delphine Planas, Sandrine Imbeaud, et al.Nature|March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.Nature|June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.Plos One|January 12, 2018
Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infectionNadia Echebli, Nicolas Tchitchek, Stéphanie Dupuy, et al.Neuroepidemiology|July 1, 2021
Characteristics Associated with Olfactory and Taste Disorders in COVID-19Simon Galmiche, Timothée Bruel, Yoann Madec, et al.Nature Communications|March 4, 2016
Elimination of HIV-1-infected cells by broadly neutralizing antibodiesTimothée Bruel, Florence Guivel-Benhassine, Sonia Amraoui, et al.Pageof 10